0.828
0.00 (0.16%)
| Previous Close | 0.827 |
| Open | 0.840 |
| Volume | 114,565 |
| Avg. Volume (3M) | 108,293 |
| Market Cap | 27,419,960 |
| Price / Book | 8.80 |
| 52 Weeks Range |
| Diluted EPS (TTM) | -0.110 |
| Total Debt/Equity (MRQ) | 6.71% |
| Current Ratio (MRQ) | 1.91 |
| Operating Cash Flow (TTM) | -4.91 M |
| Levered Free Cash Flow (TTM) | -3.59 M |
| Return on Assets (TTM) | -99.87% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bearish | Bearish |
| Biotechnology (Global) | Bearish | Bearish | |
| Stock | Jupiter Neurosciences, Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 0.13 |
|
Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| % Held by Insiders | 54.21% |
| % Held by Institutions | 1.17% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 09 Jun 2025 | Announcement | Jupiter Neurosciences Launches Nugevia™: A Premium Longevity and Performance Supplement Line Grounded in Clinical Science |
| 08 Apr 2025 | Announcement | Jupiter Neurosciences Highlights Upcoming Milestones in Shareholder Letter |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |